Risk factor
Fair trading liquidity
Profitability factor
Slightly undervalued vs peers
About
Operating within China, PKU HealthCare Corp.,Ltd. is a pharmaceutical company that specializes in the research, development, manufacturing, and distribution of medicinal products. Its extensive portfolio encompasses a broad spectrum of therapeutic areas, offering medications for conditions such as cancer (anti-tumor, oncology), neuropsychiatric disorders, cardiovascular issues, immune system regulation (immunosuppressive), infections (antimicrobial), pain and fever (antipyretic and analgesic), digestive ailments, allergies, blood sugar management, mental health, and blood volume expansion. Founded in 1965, the company was initially known as PUK International Hospital Group Southwest Synthetic Pharmaceutical Corp., Ltd. before officially rebranding to PKU HealthCare Corp.,Ltd. in November 2013. Its primary operations are based out of its headquarters in Chongqing, China.
Company Valuation
Considering past and projected metrics, the stock is slightly 'cheaper' than its peers. Specifically, the stock is 'expensive' on P/E, neutral on EV/EBITDA, underpriced o